3016Long-term survival and safety with selexipag in patients with pulmonary arterial hypertension: results from the GRIPHON study and its open-label extension | Zendy

AI Assistant Blog Pricing

3016Long-term survival and safety with selexipag in patients with pulmonary arterial hypertension: results from the GRIPHON study and its open-label extension

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.